Startups

Laplace: $22 Million Raised For Transcatheter Tricuspid Valve Technology

By Amit Chowdhry ● Mar 17, 2025

Laplace Interventional, a Minnesota-based medical device company developing a transcatheter tricuspid valve technology, announced that it has completed its Series C financing led by a non-disclosed global strategic investor along with investments from Aphelion Capital, Engage Venture Partners, Unorthodox Ventures, JWC Venture and Features Capital. The company also announced the addition of Ned Scheetz, Founding Managing Partner at Aphelion Capital, to its Board of Directors.

Aryon Security: $9 Million (Seed) Secured For Transforming Cloud Security

By Amit Chowdhry ● Mar 17, 2025

Aryon Security announced it exited stealth with its Cloud Security Enforcement Platform, which is creating a transformative approach to enterprise cloud security that prevents cloud risks before they are deployed in production systems, which is an industry first. Created by alumni of the elite Matzov unit in the Israel Defense Forces, Aryon has raised $9 million in seed funding led by Viola Ventures and Blumberg Capital.

Cino: €3.5 Million Raised To Transform Shared Payments With Virtual Cards To Split Bills

By Amit Chowdhry ● Mar 17, 2025

Cino—a real-time shared payment app that finally lets people pay together in a seamless, single transaction—announced it has raised €3.5 million in seed funding led by Balderton Capital. Connect Ventures and leading angels, including Barney Hussey-Yeo (founder of Cleo), also participated. This funding will support Cino’s launch in the UK, which already has a growing waitlist, and continued growth across Europe.

Lumafield: $75 Million (Series C) Raised For X-Ray CT Technology

By Amit Chowdhry ● Mar 16, 2025

Lumafield, a developer of industrial X-ray CT technology, announced it has closed a $75 million Series C funding round. This funding cements the company’s position as a leader in advanced manufacturing as the U.S. renews its focus on manufacturing supremacy and companies around the world reconfigure their supply chains in response to strategic threats. IVP led the round, which includes new investors G2 Venture Partners and Wellington Management along with existing investors Spark Capital, DCVC, Kleiner Perkins, Lux Capital, and Matter Venture Partners.

Accropeutics: $12 Million (Series B+) Closed For Developing Therapeutics For Immune Mediated Diseases

By Amit Chowdhry ● Mar 16, 2025

Accropeutics, a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune-mediated diseases, announced the closing of its $12 million Series B Plus financing. This funding round was led by Shenzhen Capital Group (SCGC), an existing investor, with participation from Morningside Ventures, also an existing investor, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST).

Accenture Investing In OPAQUE For Advancing Confidential AI And Data Solutions

By Amit Chowdhry ● Mar 16, 2025

Accenture announced it has made a strategic investment in OPAQUE, a provider of a confidential AI platform that empowers organizations to run cloud-scale, general-purpose AI-based workloads using encrypted data and governed data sharing, with a focus on privacy, sovereignty, and compliance. This funding, made through Accenture Ventures, underscores Accenture’s commitment to accelerating AI adoption by helping enterprises unlock the full value of sensitive data.

MicroTransponder: $65 Million (Series F) Raised For Enhancing Vivistim Adoption For Chronic Stroke Recovery

By Amit Chowdhry ● Mar 16, 2025

MicroTransponder - which is one of the fastest-growing stroke companies - announced it is transforming the stroke continuum of care with its FDA-approved Vivistim Paired VNS System. The company also announced it has raised $75 million led by US Venture Partners (USVP) and the syndicate of current investors, Osage University Partners, Action Potential Venture Capital, GPG Ventures, The Vertical Group and Exceller Hunt Ventures, as well as two new investors, Gilde Healthcare and Longitude Capital.

Motivity: $27 Million Raised For Applied Behavior Analysis Solutions

By Amit Chowdhry ● Mar 16, 2025

Motivity, a provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with autism, announced a $27 million investment from Five Elms Capital. This funding enables Motivity to accelerate product innovation, expand its team, and strengthen support for ABA providers worldwide.

Perfuze: €22 Million Raised And Clearance Received For Zipline Access Catheters

By Amit Chowdhry ● Mar 15, 2025

Perfuze, a leading medical device company dedicated to advancing stroke treatment, has received FDA 510(k) clearance for its Zipline Access Catheters. This milestone strengthens Perfuze’s growing portfolio of innovative neurovascular devices, enabling physicians to treat acute ischemic strokes rapidly, easily, and precisely. Plus, Perfuze has secured €22 million in follow-on funding in a round led by existing investors, including Earlybird, EQT Life Sciences, Seroba, and SV Health.

Phoenix: $50 Million Raised For Digital Health Clinic For Men

By Amit Chowdhry ● Mar 15, 2025

Phoenix, which is Canada’s leading digital health clinic for men, announced it has signed a CAD 50 million Series A financing round. This funding round was led by Valspring Capital, with renewed investment from Y Combinator, and support from CIBC Innovation Banking.

Human Computer: $5.7 Million (Seed) Raised For Creating Story-Driven Games

By Amit Chowdhry ● Mar 15, 2025

Human Computer, an independent game studio and a collaborative creative powerhouse, announced it has raised $5.7 million in a seed round led by Makers Fund. a16z and former Airbnb COO Belinda Johnson have also invested in the company, bringing the total funding to date to $7.7 million.

Terabase: $130 Million (Series C) Raised For Utility-Scale Solar Power Solutions

By Amit Chowdhry ● Mar 15, 2025

Terabase Energy, a leader in digital and automation solutions for utility-scale solar power, announced the closing of its $130 million Series C financing round. The funding round—led by SoftBank Vision Fund 2 and with participation from both existing and new strategic investors—brings the company's total funding to over $200 million.

W3i Software: $1.5 Million Raised From Hoskinson Family Office

By Amit Chowdhry ● Mar 15, 2025

Hoskinson Family Office (HFO) announced it has invested $1.5 million in W3i Software, Inc., the development company behind USDM—Cardano’s first MiCA-compliant, fiat-backed stablecoin. This investment is a major step toward bridging decentralized finance (DeFi) with the regulated financial system and accelerating Cardano’s global adoption.

Insilico Medicine: $110 Million (Series E) Raised For Advancing AI-Based Drug Discovery

By Amit Chowdhry ● Mar 15, 2025

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group with strong participation from industry- and technology-focused new investors, and continued support from global existing backers.